Company profile
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
PROVECTUS BIOPHARMACEUTICALS, INC.
15 Apr 24
4
PROVECTUS BIOPHARMACEUTICALS, INC.
9 Apr 24
4
PROVECTUS BIOPHARMACEUTICALS, INC.
26 Mar 24
4
PROVECTUS BIOPHARMACEUTICALS, INC.
22 Mar 24
4
PROVECTUS BIOPHARMACEUTICALS, INC.
18 Mar 24
4
PROVECTUS BIOPHARMACEUTICALS, INC.
28 Feb 24
4
PROVECTUS BIOPHARMACEUTICALS, INC.
28 Feb 24
4
PROVECTUS BIOPHARMACEUTICALS, INC.
20 Feb 24
4
PROVECTUS BIOPHARMACEUTICALS, INC.
16 Feb 24
4
PROVECTUS BIOPHARMACEUTICALS, INC.
1 Feb 24
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Apr 24 | Pershing Edward | 8% Unsecured Convertible Promissory Note [object Object] | Grant | Acquire A | No | No | 2.862 | - | 20.00 k | - |
6 Apr 24 | Pershing Edward | Series D-1 Convertible Preferred Stock Common Stock | Option exercise | Acquire M | No | No | 0 | 47,190 | 0.00 | 1,140,952 |
6 Apr 24 | Pershing Edward | 8% Unsecured Convertible Promissory Note [object Object] | Option exercise | Dispose M | No | No | 2.862 | - | 125.00 k | - |
26 Mar 24 | Pershing Edward | 8% Unsecured Convertible Promissory Note [object Object] | Grant | Acquire A | No | No | 400000 | - | 400.00 k | - |
21 Mar 24 | Pershing Edward | 8% Unsecured Convertible Promissory Note [object Object] | Grant | Acquire A | No | No | 25000 | - | 25.00 k | - |
17 Mar 24 | Pershing Edward | Series D-1 Convertible Preferred Stock Common Stock | Option exercise | Acquire M | No | No | 0 | 47,190 | 0.00 | 1,093,762 |
17 Mar 24 | Pershing Edward | 8% Unsecured Convertible Promissory Note [object Object] | Option exercise | Dispose M | No | No | 2.862 | - | 125.00 k | - |